牛叉诊股

[{"date":"2026.09.02","stock":"-2.34","trade":"-1.51","ind":"-1.88"},{"date":"2026.09.01","stock":"2.88","trade":"1.64","ind":"-1.02"},{"date":"2026.08.31","stock":"-1.19","trade":"-1.74","ind":"0.44"},{"date":"2026.08.28","stock":"-0.24","trade":"0.09","ind":"-0.68"},{"date":"2026.08.27","stock":"1.44","trade":"1.05","ind":"1.50"},{"date":"2026.08.26","stock":"-0.48","trade":"0.81","ind":"0.69"},{"date":"2026.08.25","stock":"3.98","trade":"2.69","ind":"-0.35"},{"date":"2026.08.24","stock":"-1.47","trade":"-1.70","ind":"-2.13"},{"date":"2026.08.21","stock":"-2.86","trade":"-3.27","ind":"0.87"},{"date":"2026.08.20","stock":"3.19","trade":"2.42","ind":"0.59"},{"date":"2026.08.19","stock":"-1.93","trade":"-1.50","ind":"-5.01"},{"date":"2026.08.18","stock":"0.00","trade":"-1.04","ind":"-0.56"},{"date":"2026.08.17","stock":"0.24","trade":"0.49","ind":"2.44"},{"date":"2026.08.14","stock":"-0.24","trade":"-0.81","ind":"0.45"},{"date":"2026.08.13","stock":"1.22","trade":"1.59","ind":"-0.87"},{"date":"2026.08.12","stock":"0.49","trade":"0.14","ind":"1.09"},{"date":"2026.08.11","stock":"0.74","trade":"0.34","ind":"-0.40"},{"date":"2026.08.10","stock":"4.11","trade":"0.39","ind":"0.04"},{"date":"2026.08.07","stock":"1.83","trade":"2.10","ind":"1.42"},{"date":"2026.08.06","stock":"0.26","trade":"0.32","ind":"-0.24"},{"date":"2026.08.05","stock":"-1.55","trade":"-0.59","ind":"1.86"}]

华神科技,深证成指,中药指数

压力支撑

该股压力位为4.19元，支撑位为4.12元。

[{"text":"\u538b\u529b\u4f4d","value":"4.19","date":1788278400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"4.12","date":1788278400,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前正处于反弹阶段，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：4.8资金面打败了54%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

中药行业，近5日资金流出较多，不建议投资者关注该行业的个股。

更新时间：09月02日 20:30

机构今日流向(万元)	-2103.36	机构5日流向(万元)	-5560.88
机构10日流向(万元)	-9527.34	机构20日流向(万元)	-18820.59

机构持仓

2026-06-30 与 2025-12-31 相比，主力机构持仓量增加2144.25万股，其中基金数没有增加，主力净增仓14家，有一定的中长期投资价值。

截止2026-06-30，共46家主力机构（基金43家，QFII1家，一般法人2家），持仓量总计14505.19万股，占流通A股23.30%
其中，基金持仓与2025-12-31相比：
增仓：4家，增持 25.72万股
减仓：4家，减持 118.29万股
新出现在主力名单中：36家，持有2750.38万股
从主力名单中消失：22家，原持有513.56万股

消息面诊股

诊断结果：5.8消息面打败了12%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	股东大会	临时股东大会	2026-08-24
一般消息	分红转增	不分配不转增	2026-08-24
利好	业绩预告	预计扭亏	2026-07-15
一般消息	重大事项	关联交易	2026-07-11
一般消息	分红转增	不分配不转增	2026-03-31
一般消息	重大事项	关联交易	2026-03-31
重大利空	业绩预告	预计增亏	2026-01-31
	股票增发	交易所审核通过	2026-01-24
重大利空	业绩预告	预计增亏	2026-01-24
一般消息	募资投向	公司出售资产	2026-01-06
一般消息	高管变动	因个人原因	2025-12-30
利空	重大事项	公司违规：处罚类型	2025-12-19
利空	重大事项	公司违规：处罚类型	2025-12-05
一般消息	高管变动	取消监事会	2025-12-02

一年消息统计

	所有消息	重大消息	非重大消息
利好	1条	0条	1条
利空	4条	2条	2条

行业面诊股

诊断结果：7.0行业面打败了81%的股票中药行业最新资金流向

近10日来该行业走势不明显，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，跑赢大盘。

[{"date":"2026.09.02","price":"-1.88","value":"1.64"},{"date":"2026.09.01","price":"-1.02","value":"-1.74"},{"date":"2026.08.31","price":"0.44","value":"0.09"},{"date":"2026.08.28","price":"-0.68","value":"1.05"},{"date":"2026.08.27","price":"1.50","value":"0.81"},{"date":"2026.08.26","price":"0.69","value":"2.69"},{"date":"2026.08.25","price":"-0.35","value":"-1.70"},{"date":"2026.08.24","price":"-2.13","value":"-3.27"},{"date":"2026.08.21","price":"0.87","value":"2.42"},{"date":"2026.08.20","price":"0.59","value":"-1.50"},{"date":"2026.08.19","price":"-5.01","value":"-1.04"},{"date":"2026.08.18","price":"-0.56","value":"0.49"},{"date":"2026.08.17","price":"2.44","value":"-0.81"},{"date":"2026.08.14","price":"0.45","value":"1.59"},{"date":"2026.08.13","price":"-0.87","value":"0.14"},{"date":"2026.08.12","price":"1.09","value":"0.34"},{"date":"2026.08.11","price":"-0.40","value":"0.39"},{"date":"2026.08.10","price":"0.04","value":"2.10"},{"date":"2026.08.07","price":"1.42","value":"0.32"},{"date":"2026.08.06","price":"-0.24","value":"-0.59"},{"date":"2026.08.05","price":"1.86","value":"0.61"}]

深证成指,中药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	汉森制药	46.57%	-21.62%	5.8分
2	千金药业	33.20%	17.60%	6.0分
3	精华制药	19.61%	13.01%	5.4分
4	方盛制药	17.88%	9.54%	6.2分
5	沃华医药	17.25%	10.47%	6.2分
6	粤万年青	16.53%	3.07%	4.5分
7	太龙药业	15.59%	7.50%	5.6分
8	古汉医药	11.74%	0.63%	5.9分
9	华森制药	11.56%	-10.06%	5.3分
10	益佰制药	11.52%	-2.70%	5.4分
11	佛慈制药	11.51%	0.23%	6.1分
12	新天药业	10.51%	-0.69%	6.4分
13	三力制药	10.46%	-4.64%	4.7分
14	益盛药业	10.08%	1.43%	6.1分
15	华神科技	9.71%	0.48%	6.0分
16	振东制药	9.54%	5.15%	5.5分
17	ST嘉应	6.49%	2.85%	5.7分
18	新光药业	6.28%	-2.93%	4.9分
19	-	6.22%	2.95%	分
20	康惠股份	6.18%	8.10%	5.1分
21	-	5.37%	4.08%	分
22	恩威医药	4.55%	-1.04%	5.3分
23	ST葫芦娃	4.15%	-0.17%	5.0分
24	信邦制药	4.08%	-1.29%	6.0分
25	维康药业	4.03%	0.37%	5.5分
26	康恩贝	3.50%	-0.23%	6.2分
27	盘龙药业	3.25%	-2.83%	5.2分
28	中恒集团	2.71%	-1.73%	5.2分
29	天目药业	2.36%	11.89%	6.9分
30	寿仙谷	1.84%	1.02%	4.9分
31	健民集团	1.82%	3.14%	5.9分
32	康美药业	1.46%	0.00%	5.5分
33	仁和药业	0.93%	-1.45%	5.2分
34	亚宝药业	0.59%	-5.16%	5.6分
35	ST百灵	0.00%	0.00%	5.7分
36	ST金花	0.00%	1.03%	5.5分
37	康缘药业	-0.16%	2.28%	6.2分
38	陇神戎发	-0.37%	-20.89%	4.4分
39	吉林敖东	-0.38%	-1.30%	5.6分
40	九芝堂	-0.44%	0.33%	6.2分
41	云南白药	-0.59%	0.70%	6.7分
42	红日药业	-1.47%	-2.62%	5.1分
43	马应龙	-2.16%	-0.30%	5.3分
44	特一药业	-2.18%	1.24%	5.4分
45	奇正藏药	-2.33%	-0.74%	5.8分
46	上海凯宝	-2.70%	-5.43%	4.4分
47	昆药集团	-3.40%	-1.96%	4.5分
48	达仁堂	-3.86%	-1.97%	5.8分
49	以岭药业	-4.20%	-1.81%	5.4分
50	步长制药	-4.20%	-4.32%	5.0分
51	佐力药业	-4.25%	-5.26%	5.4分
52	济川药业	-4.58%	-0.04%	5.9分
53	华润三九	-4.66%	-1.27%	5.6分
54	同仁堂	-4.94%	-2.49%	5.0分
55	广誉远	-5.01%	-0.66%	5.6分
56	桂林三金	-5.63%	0.00%	5.7分
57	白云山	-6.33%	-1.66%	5.4分
58	天士力	-6.93%	-0.95%	5.7分
59	华润江中	-8.14%	-1.02%	5.7分
60	片仔癀	-10.18%	-3.53%	5.4分
61	东阿阿胶	-10.38%	-0.08%	5.5分
62	葵花药业	-10.73%	-10.67%	4.9分
63	ST万邦	-11.21%	-9.08%	5.0分
64	众生药业	-11.23%	-0.77%	5.6分
65	太极集团	-11.75%	-3.54%	4.9分
66	羚锐制药	-12.77%	-0.46%	6.2分
67	*ST香雪	-13.50%	-6.27%	3.8分
68	珍宝岛	-13.79%	0.35%	4.8分

<上一页 1 2 3 4 5...12 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：5.6基本面打败了41%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，暂时未获得多数机构的显著认同，后续可继续关注。

个股深一度

潜在高分红能力：弱（37.5分）

基本面得分最高的股票

[ 截止日期：2026-06-30 ]公司经营

盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 51/109 ， 48/109。

[{"date":"2026-06-30","value":"0.85","vol":"3.25"},{"date":"2026-03-31","value":"0.34","vol":"2.21"},{"date":"2025-12-31","value":"-36.80","vol":"-2.33"},{"date":"2025-09-30","value":"-9.99","vol":"4.80"},{"date":"2025-06-30","value":"-5.48","vol":"4.03"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
净资产收益率(%)	0.85	0.34	-36.80	-9.99	-5.48
行业(%)	3.25	2.21	-2.33	4.80	4.03

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"43.40","vol":"53.70"},{"date":"2026-03-31","value":"42.61","vol":"55.05"},{"date":"2025-12-31","value":"47.61","vol":"52.85"},{"date":"2025-09-30","value":"45.48","vol":"53.29"},{"date":"2025-06-30","value":"48.77","vol":"53.82"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
销售毛利率(%)	43.40	42.61	47.61	45.48	48.77
行业(%)	53.70	55.05	52.85	53.29	53.82

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 53/109 ， 5/109。

[{"date":"2026-06-30","value":"-20.16","vol":"-9.08"},{"date":"2026-03-31","value":"-13.90","vol":"-5.58"},{"date":"2025-12-31","value":"-36.86","vol":"-6.76"},{"date":"2025-09-30","value":"-31.02","vol":"-7.84"},{"date":"2025-06-30","value":"-36.29","vol":"-7.78"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
营业收入同比增长率(%)	-20.16	-13.90	-36.86	-31.02	-36.29
行业(%)	-9.08	-5.58	-6.76	-7.84	-7.78

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"111.14","vol":"-101.51"},{"date":"2026-03-31","value":"116.56","vol":"1.06"},{"date":"2025-12-31","value":"-4689.37","vol":"-80.25"},{"date":"2025-09-30","value":"-1804.21","vol":"-2.78"},{"date":"2025-06-30","value":"-702.09","vol":"2.25"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
净利润同比增长率(%)	111.14	116.56	-4689.37	-1804.21	-702.09
行业(%)	-101.51	1.06	-80.25	-2.78	2.25

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 43/109 ， 6/109。

[{"date":"2026-06-30","value":"0.17","vol":"0.22"},{"date":"2026-03-31","value":"0.08","vol":"0.12"},{"date":"2025-12-31","value":"0.30","vol":"0.47"},{"date":"2025-09-30","value":"0.22","vol":"0.35"},{"date":"2025-06-30","value":"0.13","vol":"0.24"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
总资产周转率(次)	0.17	0.08	0.30	0.22	0.13
行业(次)	0.22	0.12	0.47	0.35	0.24

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"2.15","vol":"1.14"},{"date":"2026-03-31","value":"1.08","vol":"0.59"},{"date":"2025-12-31","value":"3.39","vol":"2.34"},{"date":"2025-09-30","value":"2.89","vol":"1.72"},{"date":"2025-06-30","value":"1.42","vol":"1.17"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
存货增长率(次)	2.15	1.08	3.39	2.89	1.42
行业(次)	1.14	0.59	2.34	1.72	1.17

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 52/109 ， 34/109。

[{"date":"2026-06-30","value":"3.33","vol":"20.65"},{"date":"2026-03-31","value":"-17.54","vol":"5.83"},{"date":"2025-12-31","value":"108.63","vol":"30.77"},{"date":"2025-09-30","value":"3.17","vol":"10.53"},{"date":"2025-06-30","value":"-4.07","vol":"22.82"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
现金流量净额/营业收入	3.33	-17.54	108.63	3.17	-4.07
行业	20.65	5.83	30.77	10.53	22.82

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"0.57","vol":"0.88"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"1.26","vol":"1.00"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.68","vol":"1.03"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
资本支出／折旧和摊销	0.57	-	1.26	-	1.68
行业	0.88	0.00	1.00	0.00	1.03

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 39/109 ， 24/109。

[{"date":"2026-06-30","value":"0.80","vol":"3.10"},{"date":"2026-03-31","value":"0.80","vol":"2.97"},{"date":"2025-12-31","value":"0.78","vol":"2.94"},{"date":"2025-09-30","value":"0.68","vol":"3.09"},{"date":"2025-06-30","value":"0.78","vol":"2.94"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
流动比率	0.80	0.80	0.78	0.68	0.78
行业	3.10	2.97	2.94	3.09	2.94

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"0.64","vol":"2.34"},{"date":"2026-03-31","value":"0.66","vol":"2.23"},{"date":"2025-12-31","value":"0.65","vol":"2.15"},{"date":"2025-09-30","value":"0.59","vol":"2.24"},{"date":"2025-06-30","value":"0.64","vol":"2.15"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
速动比率	0.64	0.66	0.65	0.59	0.64
行业	2.34	2.23	2.15	2.24	2.15

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 1/109 ， 7/109。

[{"date":"2026-06-30","value":"49.59","vol":"32.07"},{"date":"2026-03-31","value":"49.13","vol":"31.94"},{"date":"2025-12-31","value":"49.12","vol":"32.43"},{"date":"2025-09-30","value":"48.98","vol":"31.59"},{"date":"2025-06-30","value":"51.24","vol":"32.45"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
资产负债率(%)	49.59	49.13	49.12	48.98	51.24
行业(%)	32.07	31.94	32.43	31.59	32.45

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"0.97","vol":"0.68"},{"date":"2026-03-31","value":"0.95","vol":"0.66"},{"date":"2025-12-31","value":"0.95","vol":"0.67"},{"date":"2025-09-30","value":"0.98","vol":"0.76"},{"date":"2025-06-30","value":"1.10","vol":"0.75"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
产权比率 (%)	0.97	0.95	0.95	0.98	1.10
行业(%)	0.68	0.66	0.67	0.76	0.75

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2026年的收益，请投资者后续关注。

[{"date":"2022","yellowRectValue":"0.41","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.28","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-0.07","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-3.20","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[华神科技]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]